An Act to expand access to Naloxone
Senate, March 24, 2022 -- The committee on Public Health, to whom was referred the petitions (accompanied by bill, Senate, No. 1393) of Brendan P. Crighton for legislation to expand access to Naloxone; and (accompanied by bill, House, No. 2361) of Elizabeth A. Malia for legislation to expand naloxone access, reports the accompanying bill (Senate, No. 2780).
Bill History
Date | Branch | Action |
---|---|---|
3/24/2022 | Senate | Reported from the committee on Public Health |
3/24/2022 | Senate | New draft of S1393 and H2361 |
3/24/2022 | Senate | Bill reported favorably by committee and referred to the committee on Health Care Financing |
3/31/2022 | House | Reporting date extended to Wednesday June 1, 2022, pending concurrence |
5/26/2022 | Senate | Senate concurred |
6/9/2022 | Senate | Committee recommended ought to pass and referred to the committee on Senate Ways and Means |
1/3/2023 | Senate | Committee recommended ought to pass with an amendment, substituting a new draft, see S3182 |
1/3/2023 | Senate | Rules suspended |
1/3/2023 | Senate | Read second |
1/3/2023 | Senate | New draft substituted, see S3182 |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.